The present adenosine A2A receptor antagonists-induced increase of discharge frequency indicated that adenosine A2A receptor antagonists may contribute to alleviating motor symptoms in Parkinson's disease by normalizing the firing rate of pallidal neurons. Here, ADORA2A is linked to Parkinson disease.